Education
About Us
Working with TipRanks
Follow Us
Illumina (GB:0J8Z)
LSE:0J8Z
Earnings Data
Report Date
Feb 05, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.2Last Year’s EPS
0.95Same Quarter Last Year
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress in clinical markets and the NovaSeq X transition, with revenue and earnings exceeding expectations. However, challenges in research markets and ongoing issues in China present hurdles. Despite these challenges, the company remains optimistic about its strategic initiatives and future growth.Company Guidance
Revenue Exceeds Guidance
Total revenue of $1.08 billion, above guidance range. Non-GAAP operating margin was 24.5% and non-GAAP diluted EPS was $1.34, both above guidance.
Strong Performance in Clinical Markets
Sequencing consumables revenue grew at a high single-digit rate year-over-year. Clinical remains a primary driver, supported by new assay approvals and increased demand for sequencing-intensive tests.
Successful NovaSeq X Transition
More than 55 instruments placed in Q3, exceeding the goal of 50-60 placements per quarter. 78% of volumes and 51% of revenue in Q3 were sequenced on the NovaSeq X.
Expansion in Multiomics
Launch of Illumina Protein Prep and expansion of the multiomics portfolio with the 5-base solution. Progressing with the acquisition of SomaLogic, expected to close in 2026.
Increased Full-Year Outlook
Raising full-year 2025 outlook due to strong Q3 performance and resilience in clinical markets.
GB:0J8Z Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:0J8Z Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $97.91 | $121.44 | +24.03% |
Jul 31, 2025 | $104.11 | $95.33 | -8.43% |
May 08, 2025 | $79.70 | $76.17 | -4.43% |
Feb 06, 2025 | $122.89 | $112.14 | -8.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Illumina (GB:0J8Z) report earnings?
Illumina (GB:0J8Z) is schdueled to report earning on Feb 05, 2026, After Close (Confirmed).
What is Illumina (GB:0J8Z) earnings time?
Illumina (GB:0J8Z) earnings time is at Feb 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Illumina stock?
The P/E ratio of Illumina is N/A.
What is GB:0J8Z EPS forecast?
GB:0J8Z EPS forecast for the fiscal quarter 2025 (Q4) is 1.2.
